Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report)’s stock price was up 7.1% during trading on Wednesday . The stock traded as high as $11.34 and last traded at $10.98. Approximately 23,896 shares traded hands during trading, a decline of 33% from the average daily volume of 35,403 shares. The stock had previously closed at […]
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) insider Leslie Tari sold 21,029 shares of Cidara Therapeutics stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $0.67, for a total value of $14,089.43. Following the sale, the insider now directly owns 258,681 shares in the […]
Pale Fire Capital SE purchased a new position in shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 54,356 shares of the biotechnology company’s stock, valued at approximately $51,000. Pale Fire Capital SE […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 1,240,000 shares, a decline of 6.1% from the October 15th total of 1,320,000 shares. Based on an average trading volume of 466,800 shares, […]